efaroxan

Known as: 2-((2-ethyl-2,3-dihydrobenzofuran-2-yl))-2-imidazoline 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2006
2006
The monomeric G-protein Rhes has been described to be present in pancreatic beta-cells, and a putative role in the control of… (More)
Is this relevant?
2005
2005
Interleukin (IL)-1beta-treated rat islets of Langerhans were exposed in vitro either to the imidazoline compound, Efaroxan, or to… (More)
Is this relevant?
2003
2003
CONTEXT Certain imidazoline drugs stimulate insulin secretion acutely but their longer term effects on the viability of… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2002
2002
Efaroxan induces membrane depolarization by interaction with the pore forming subunit of the ATP-sensitive potassium channel… (More)
Is this relevant?
2001
2001
Efaroxan, like several other imidazoline reagents, elicits a glucose-dependent increase in insulin secretion from pancreatic beta… (More)
Is this relevant?
1999
1999
The properties of ATP-sensitive K+ (K(ATP)) channels were explored in the electrofusion-derived, glucose-responsive, insulin… (More)
Is this relevant?
1999
1999
We have employed an amino derivative of the imidazoline ligand, efaroxan, to isolate imidazoline binding proteins from… (More)
Is this relevant?
1998
1998
We have tested, in a prospective randomized, double-blind, placebo-controlled, crossover, 12-week study, the effects of 2 mg… (More)
Is this relevant?
1991
1991
The actions of efaroxan, a highly selective and potent alpha 2-adrenoceptor antagonist, on insulin secretion, cAMP levels, 86Rb… (More)
Is this relevant?
1990
1990
The imidazoline alpha 2-antagonist efaroxan was found to stimulate insulin secretion from isolated rat pancreatic islets… (More)
Is this relevant?